Original article
The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis
Seguridad y eficacia de tolvaptan en el tratamiento de los pacientes con enfermedad renal poliquística autosómica dominante: Revisión sistemática y metaanálisis
a Division of Nephrology, The First College of Clinical Medical Science, Three Gorges University, Yichang, Hubei, China
b Division of Endocrinology, The Renhe Hospital of Three Gorges University, Yichang, Hubei, China
c Division of Urinary Surgery, The First College of Clinical Medical Science, Three Gorges University , Yichang, Hubei, China
Read
4452
Timeswas read the article
1687
Total PDF
2765
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 33 | 5 | 38 |
| 2025 5 | 194 | 82 | 276 |
| 2025 4 | 123 | 54 | 177 |
| 2025 3 | 195 | 90 | 285 |
| 2025 2 | 144 | 93 | 237 |
| 2025 1 | 128 | 97 | 225 |
| 2024 12 | 118 | 55 | 173 |
| 2024 11 | 130 | 93 | 223 |
| 2024 10 | 155 | 80 | 235 |
| 2024 9 | 127 | 66 | 193 |
| 2024 8 | 139 | 96 | 235 |
| 2024 7 | 131 | 43 | 174 |
| 2024 6 | 144 | 82 | 226 |
| 2024 5 | 149 | 91 | 240 |
| 2024 4 | 126 | 51 | 177 |
| 2024 3 | 108 | 47 | 155 |
| 2024 2 | 93 | 64 | 157 |
| 2024 1 | 42 | 35 | 77 |
| 2023 12 | 40 | 31 | 71 |
| 2023 11 | 61 | 77 | 138 |
| 2023 10 | 76 | 80 | 156 |
| 2023 9 | 68 | 64 | 132 |
| 2023 8 | 70 | 48 | 118 |
| 2023 7 | 60 | 60 | 120 |
| 2023 6 | 78 | 38 | 116 |
| 2023 5 | 33 | 65 | 98 |
Show all
